Clinical Trial

Evaluating the Barrier Function, Regenerative Capacity, and Soft Tissue Outcomes of Acellular Dermal Matrix

Name: Evaluating the Barrier Function, Regenerative Capacity, and Soft Tissue Outcomes of Acellular Dermal Matrix — clinical trial record (NCT07613047)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This investigator-initiated study will compare ADM and resorbable cross-linked collagen membrane barriers for guided bone regeneration at atrophic lateral ridge augmentation sites.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-05-21.

Trial Details

NCT Number	NCT07613047
Lead Sponsor	University of Alabama at Birmingham
Conditions	Acellular Dermal Matrix, Bone Grafting, Soft Tissue Grafting
Enrollment	70 participants
Start Date	2026-10
Primary Completion	2027-10 (estimated)
Study Completion	2028-10 (estimated)
Updated on ClinicalTrials.gov	2026-06-01